The Valley Desk

NCT05132582 · Interventional trial

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

Overall registry status Active not recruiting

Phase 3

Conditions HER2 Positive Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov